DENALI THERAPEUTICS INC's ticker is and the CUSIP is 24823R905. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,063 | -98.1% | 100 | -97.3% | 0.00% | – |
| Q2 2023 | $109,187 | +3.3% | 3,700 | -2.6% | 0.00% | – |
| Q4 2022 | $105,678 | +92.1% | 3,800 | +111.1% | 0.00% | – |
| Q3 2022 | $55,000 | +358.3% | 1,800 | +350.0% | 0.00% | – |
| Q2 2022 | $12,000 | +300.0% | 400 | +300.0% | 0.00% | – |
| Q1 2022 | $3,000 | -85.0% | 100 | -75.0% | 0.00% | – |
| Q3 2021 | $20,000 | -57.4% | 400 | -33.3% | 0.00% | – |
| Q2 2021 | $47,000 | -95.6% | 600 | -96.8% | 0.00% | -100.0% |
| Q1 2021 | $1,062,000 | +71.3% | 18,600 | +151.4% | 0.00% | +100.0% |
| Q4 2020 | $620,000 | +119.1% | 7,400 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $283,000 | +1564.7% | 7,900 | +1028.6% | 0.00% | – |
| Q2 2020 | $17,000 | -94.2% | 700 | -95.8% | 0.00% | -100.0% |
| Q1 2020 | $292,000 | +1023.1% | 16,700 | +1013.3% | 0.00% | – |
| Q4 2019 | $26,000 | +23.8% | 1,500 | +50.0% | 0.00% | – |
| Q2 2019 | $21,000 | -52.3% | 1,000 | -47.4% | 0.00% | – |
| Q1 2019 | $44,000 | +528.6% | 1,900 | +533.3% | 0.00% | – |
| Q3 2018 | $7,000 | +40.0% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $2,063 | 0.00% |
| SIMPLEX TRADING, LLC | 1,300 | $26 | 0.00% |
| JANE STREET GROUP, LLC | 20,700 | $427,041 | 0.00% |